Streptozotocin, Type I Diabetes Severity and Bone

Abstract

As many as 50% of adults with type I (T1) diabetes exhibit bone loss and are at increased risk for fractures. Therapeutic development to prevent bone loss and/or restore lost bone in T1 diabetic patients requires knowledge of the molecular mechanisms accounting for the bone pathology. Because cell culture models alone cannot fully address the systemic… (More)
DOI: 10.1007/s12575-009-9000-5

8 Figures and Tables

Topics

  • Presentations referencing similar topics